| 221 |
Functional and Biological Implications of CUX1 Mutations and Deletions in Myeloid Neoplasms |
2017 |
| 222 |
Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function. |
2017 |
| 223 |
Hematogones as a Prognostic Indicator in Allogeneic Hematopoietic Stem Cell
Transplantation: Single Center Experience |
2017 |
| 224 |
Hematogones as a Prognostic Indicator in Allogeneic Hematopoietic Stem Cell
Transplantation: Single Center Experience |
2017 |
| 225 |
High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis |
2017 |
| 226 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 227 |
Impact of Comorbidities on Outcome of Diffuse Large B Cell Lymphoma (DLBCL) |
2017 |
| 228 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 229 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |
| 230 |
Low utility of serum 25–hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in predicting peripheral Treg and Th17 cell counts in ESRD and renal transplant patients |
2017 |